Covered recipient · General Payments record
COURTNEY STULL
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2024–2025
$371.89
- Reported across 12 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $319.64 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $93.48 | 1 |
| UCB, Inc. | $90.38 | 3 |
| Amgen Inc. | $49.84 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $33.36 | 1 |
| GlaxoSmithKline, LLC. | $18.48 | 1 |
| PFIZER INC. | $17.77 | 1 |
| Lilly USA, LLC | $16.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $93.48 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204433373 | CMS |
| Amgen Inc. | $20.73 | 11/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228299072 | CMS |
| Amgen Inc. | $29.11 | 12/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228299070 | CMS |
| GlaxoSmithKline, LLC. | $18.48 | 12/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190781609 | CMS |
| Lilly USA, LLC | $16.33 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186574780 | CMS |
| Novartis Pharmaceuticals Corporation | $33.36 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200457987 | CMS |
| PFIZER INC. | $17.77 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231556407 | CMS |
| UCB, Inc. | $21.42 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224538098 | CMS |
| UCB, Inc. | $43.97 | 03/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224538100 | CMS |
| UCB, Inc. | $24.99 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224538102 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.